NZ252717A - Adamantane-pyridine derivatives and medicaments - Google Patents

Adamantane-pyridine derivatives and medicaments

Info

Publication number
NZ252717A
NZ252717A NZ252717A NZ25271793A NZ252717A NZ 252717 A NZ252717 A NZ 252717A NZ 252717 A NZ252717 A NZ 252717A NZ 25271793 A NZ25271793 A NZ 25271793A NZ 252717 A NZ252717 A NZ 252717A
Authority
NZ
New Zealand
Prior art keywords
mmol
compounds
adamantyl
pct
ether
Prior art date
Application number
NZ252717A
Other languages
English (en)
Inventor
Ferdinand Chan
Michael Jarman
Gerard Andrew Potter
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929210489A external-priority patent/GB9210489D0/en
Priority claimed from GB929223738A external-priority patent/GB9223738D0/en
Application filed by British Tech Group filed Critical British Tech Group
Publication of NZ252717A publication Critical patent/NZ252717A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ252717A 1992-05-15 1993-04-29 Adamantane-pyridine derivatives and medicaments NZ252717A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929210489A GB9210489D0 (en) 1992-05-15 1992-05-15 Heterocyclic compounds,their preparation and pharmaceutical use
GB929223738A GB9223738D0 (en) 1992-11-12 1992-11-12 Heterocyclic compounds,their preparation and pharmaceutical use

Publications (1)

Publication Number Publication Date
NZ252717A true NZ252717A (en) 1996-05-28

Family

ID=26300892

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ252717A NZ252717A (en) 1992-05-15 1993-04-29 Adamantane-pyridine derivatives and medicaments

Country Status (15)

Country Link
US (1) US5595995A (enExample)
EP (1) EP0640072B1 (enExample)
JP (1) JPH07506588A (enExample)
KR (1) KR100235976B1 (enExample)
AT (1) ATE195728T1 (enExample)
AU (1) AU673837B2 (enExample)
CA (1) CA2134563A1 (enExample)
DE (1) DE69329281T2 (enExample)
ES (1) ES2149817T3 (enExample)
IL (1) IL105666A (enExample)
MX (1) MX9302833A (enExample)
NO (1) NO302069B1 (enExample)
NZ (1) NZ252717A (enExample)
TW (1) TW223631B (enExample)
WO (1) WO1993023375A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69705772T2 (de) * 1996-05-28 2001-11-15 Pfizer Inc., New York Adamantyl substituierte Oxindole als pharmazeutische Wirkstoffe
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
JP2006160605A (ja) * 2003-07-09 2006-06-22 Nippon Kayaku Co Ltd 新規酵素阻害剤
JP2008007404A (ja) * 2004-10-08 2008-01-17 Nippon Kayaku Co Ltd 新規ピリジン誘導体
MX2007015863A (es) 2005-06-17 2008-04-02 Apogee Biotechnology Corp Inhibidores de esfingosina cinasa.
GB0803494D0 (en) * 2008-02-26 2008-04-02 Sterix Ltd Compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971797A (en) * 1973-06-15 1976-07-27 Merck & Co., Inc. S,S'-bis(pyridylmethyl)-carbonodithioates
IL83163A (en) * 1986-07-18 1991-06-10 Erba Carlo Spa Cycloalkyl-substituted 4-pyridyl derivatives,their preparation and pharmaceutical compositions containing them
DE4018260A1 (de) * 1990-06-07 1991-12-12 Basf Ag Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel

Also Published As

Publication number Publication date
NO944332D0 (no) 1994-11-14
NO302069B1 (no) 1998-01-19
ES2149817T3 (es) 2000-11-16
EP0640072A1 (en) 1995-03-01
IL105666A0 (en) 1993-09-22
ATE195728T1 (de) 2000-09-15
DE69329281T2 (de) 2001-03-15
JPH07506588A (ja) 1995-07-20
IL105666A (en) 1999-09-22
US5595995A (en) 1997-01-21
KR100235976B1 (ko) 1999-12-15
CA2134563A1 (en) 1993-11-25
EP0640072B1 (en) 2000-08-23
KR950701620A (ko) 1995-04-28
MX9302833A (es) 1993-11-01
DE69329281D1 (de) 2000-09-28
AU673837B2 (en) 1996-11-28
AU4267493A (en) 1993-12-13
NO944332L (no) 1994-11-14
TW223631B (enExample) 1994-05-11
WO1993023375A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
McCague et al. Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid
Rafferty et al. Highly-selective 4-(1, 2, 3-triazole)-based P450c17a 17, 20-lyase inhibitors
US5202243A (en) Method of hydroxylating 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone by incubation with liver slices
EP0706795A2 (en) Catechol diether compounds as inhibitors of TNF release
EP1659113A1 (en) Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
JPH01216974A (ja) 置換ピリジン類
JP5066638B2 (ja) ピリジン−１−オキシド誘導体及びその医薬的に有効な化合物へと転換する為の方法
US5972975A (en) Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
Bagal et al. Syntheses of the enantiomers of 1-deoxynojirimycin and 1-deoxyaltronojirimycin via chemo-and diastereoselective olefinic oxidation of unsaturated amines
EP0640072B1 (en) Derivatives of pyridine as hydroxylase and lyase inhibitors
KR100224153B1 (ko) 6,9-비스[(2-아미노에틸)아미노]벤조[g]이소퀴놀린-5,10-디온및 이의 디말레산염의 개선된 합성 방법
SK12022001A3 (sk) 2-aminopyridíny obsahujúce ako substituenty kondenzované kruhové skupiny
US5004748A (en) Substituted pyridine-2,4-dicarboxylic acid derivatives and medicaments based on these compounds
US10214496B2 (en) Azasteroidal mimics
JPS6233172A (ja) ド−パミン−β−ヒドロキシラ−ゼ抑制剤
IE63491B1 (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates
Deraeve et al. Chemical synthesis, biological evaluation and structure–activity relationship analysis of azaisoindolinones, a novel class of direct enoyl-ACP reductase inhibitors as potential antimycobacterial agents
GB2266887A (en) Substituted pyridines, their preparation and pharmaceutical use
FR2806722A1 (fr) Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
NZ508057A (en) 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
WO2011077046A1 (fr) Dérivés phénoliques, et leur utilisation pharmaceutique ou cosmétique
IE61385B1 (en) Derivatives of tetrahydrofuran and tetrahydrothiophen
JPH0393773A (ja) 置換アミノピリジン類
JPH0366668A (ja) イミノ置換ピリジン類
IE920900A1 (en) Heterocyclic compounds, their preparation and pharmaceutical¹use